CLSI NBS08

Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E

Clinical and Laboratory Standards Institute, 10/28/2019

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:28/10/2019

Pages:130

File Size:1 file , 8.1 MB

Note:This product is unavailable in Russia, Belarus

This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.

More CLSI standard pdf

CLSI EP29-A

CLSI EP29-A

Expression of Measurement Uncertainty in Laboratory Medicine; Approved Guideline, EP29AE

$90.00 $180.00

CLSI M02-A11 and M100-S22 Package

CLSI M02-A11 and M100-S22 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Eleventh Edition & Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement

$111.00 $222.38

CLSI M02-A11, M07-A9, M100-S22 Package

CLSI M02-A11, M07-A9, M100-S22 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Eleventh Edition / Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Ninth Edition / Performance Standards for Antimicrobial Susceptibility Testing

$108.00 $216.42

CLSI POCT10-A2 (R2018)

CLSI POCT10-A2 (R2018)

Provider-Performed Microscopy Testing; Approved Guideline, Second Edition, POCT10A2E

$147.00 $294.28